Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06284148 · ClinicalTrials.gov registry record · NA

Confidential IPV Screening Tool

A NA study of Violence, Domestic, sponsored by Medical University of South Carolina.

Completed
Registry status
NA
Development phase
19,655
Enrollment target
1
Study location

NCT06284148: Completed NA study of Violence, Domestic, sponsored by Medical University of South Carolina.

NCT06284148 is a NA study of Violence, Domestic that has completed, run by Medical University of South Carolina. The registered enrollment target is 19,655 participants, above the 1,415-participant average among 6 other Violence, Domestic trials with a reported enrollment target (1289% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06284148, a NA study of Violence, Domestic, has completed, sponsored by Medical University of South Carolina.

COMPLETED
Registry status
NA
Development phase
19,655 participants
Enrollment target
1
Study location

Study Summary

Intimate partner violence (IPV) against women in the US is a serious public health problem and a human rights issue. Our research team has developed confidential screening tools using exam-room computer for intimate partner violence to be used in primary care.

Primary Outcome

Depending on patient's answers to screening questions, they are flagged as either IPV positive or negative

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST Screening for intimate partner violence
  • OTHER Assessment and referral

Study Locations (1)

South Carolina

  • Biomedical Informatics Center - Charleston

Trial Details

FieldValue
Enrollment Target 19,655 participants
Start Date 2010-10-06
Est. Completion 2023-07-31
Phase NA

What the finished NCT06284148 record still lists

NCT06284148 is an interventional study that assigns participants to a tested intervention. Its 19,655 participants enrollment target places it among the larger protocols in the corpus, above the 1,415-participant average among 6 other Violence, Domestic trials with a reported enrollment target (1289% higher).

The record links to 1 condition, with Violence, Domestic appearing as the primary indexed condition, and to 2 interventions - of which Screening for intimate partner violence is the first listed.

NCT06284148 reports a single indexed study location in South Carolina.

Frequently Asked Questions

What is clinical trial NCT06284148 about?

NCT06284148 is a clinical study titled "Confidential IPV Screening Tool". Intimate partner violence (IPV) against women in the US is a serious public health problem and a human rights issue. Our research team has developed confidential screening tools using exam-room computer for intimate partner violence to be used in primary care.

What is the current status of trial NCT06284148?

This trial is currently completed. It is a NA study. The enrollment target is 19,655 participants. The study started on 2010-10-06. Estimated completion is 2023-07-31.

What conditions does trial NCT06284148 study?

This clinical trial studies the following conditions: Violence, Domestic.

What interventions are being tested in trial NCT06284148?

The interventions under investigation include: Screening for intimate partner violence (DIAGNOSTIC_TEST), Assessment and referral (OTHER).

Who is sponsoring clinical trial NCT06284148?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06284148 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Violence, Domestic

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07152249 · 19,480 participants · NA

    Advancing Strategies to Optimize the PerIopeRativE Management of PostOperative Nausea and Vomiting (ASPIRE-PONV) Trial

  • NCT05555095 · 19,331 participants

    Examining Digital Health Care Delivery Models Through Medicaid Collaborative

  • NCT00271180 · 20,000 participants

    Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

  • NCT00830557 · 20,000 participants

    Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06284148, the US trial registry maintained by the National Library of Medicine. NCT06284148 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.